If GLP-1 medications eventually prove beneficial for endo, they'd be an add-on to that toolkit, not a replacement for it
Does a low-carbohydrate or a ketogenic diet reduce symptoms of acid reflux
often stacked with GLP-1 Pyy 2.0 peptide YY signaling directly reduces appetite at the gut-brain axis Cagri-sema (cagrilintide + semaglutide) amylin analog + GLP-1 combo with strong satiety data Behavioral Strategies That Survive Food Noise Eat protein first : Protein triggers POMC satiety signaling faster than carbs/fat Sleep 7-8 hours : Sleep deprivation raises ghrelin 15-20% the next day Structured meal timing : Same meal times each day reduces grazing/craving triggers Eliminate food cues : Out of sight, out of mind this is underrated NAD+ and Metabolic Support Some early evidence suggests NAD+ precursors (NMN, NR) may help with metabolic flexibility and reduce the insulin-resistance signaling that drives cravings
Staying alert to such reactions helps patients, clinicians and regulators better understand the real-world safety of these medicines
You may start seeing generic GLP-1 drugs in Canada around mid-2026, but not immediately
Wang H, Khaoustov VI, Krishnan B, Cai W, Stoll B, Burrin DG, Yoffe B
